NPs Basic Information
|
Name |
(-)-citreoisocoumarin
|
| Molecular Formula | C14H16O5 | |
| IUPAC Name* |
6,8-dihydroxy-3-(2-hydroxypentyl)isochromen-1-one
|
|
| SMILES |
CCCC(O)Cc1cc2cc(O)cc(O)c2c(=O)o1
|
|
| InChI |
InChI=1S/C14H16O5/c1-2-3-9(15)6-11-5-8-4-10(16)7-12(17)13(8)14(18)19-11/h4-5,7,9,15-17H,2-3,6H2,1H3/t9-/m1/s1
|
|
| InChIKey |
LEFPJELCBFHMFS-SECBINFHSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 264.28 | ALogp: | 1.9 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 90.9 | Aromatic Rings: | 2 |
| Heavy Atoms: | 19 | QED Weighted: | 0.789 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.825 | MDCK Permeability: | 0.00000987 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.996 |
| Human Intestinal Absorption (HIA): | 0.068 | 20% Bioavailability (F20%): | 0.988 |
| 30% Bioavailability (F30%): | 0.999 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.048 | Plasma Protein Binding (PPB): | 87.38% |
| Volume Distribution (VD): | 0.689 | Fu: | 21.16% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.968 | CYP1A2-substrate: | 0.804 |
| CYP2C19-inhibitor: | 0.226 | CYP2C19-substrate: | 0.09 |
| CYP2C9-inhibitor: | 0.541 | CYP2C9-substrate: | 0.939 |
| CYP2D6-inhibitor: | 0.271 | CYP2D6-substrate: | 0.519 |
| CYP3A4-inhibitor: | 0.141 | CYP3A4-substrate: | 0.141 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 12.263 | Half-life (T1/2): | 0.806 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.143 |
| Drug-inuced Liver Injury (DILI): | 0.46 | AMES Toxicity: | 0.06 |
| Rat Oral Acute Toxicity: | 0.06 | Maximum Recommended Daily Dose: | 0.849 |
| Skin Sensitization: | 0.932 | Carcinogencity: | 0.041 |
| Eye Corrosion: | 0.054 | Eye Irritation: | 0.912 |
| Respiratory Toxicity: | 0.273 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003206 |  |
0.836 | D04AIT |  |
0.325 | ||
| ENC004556 |  |
0.750 | D0K8KX |  |
0.318 | ||
| ENC001569 |  |
0.750 | D07MGA |  |
0.284 | ||
| ENC004995 |  |
0.738 | D02UFG |  |
0.278 | ||
| ENC002320 |  |
0.738 | D0M8RC |  |
0.270 | ||
| ENC005299 |  |
0.738 | D04XEG |  |
0.270 | ||
| ENC005394 |  |
0.738 | D07EXH |  |
0.267 | ||
| ENC004438 |  |
0.738 | D02FCQ |  |
0.247 | ||
| ENC002509 |  |
0.661 | D0YF3X |  |
0.247 | ||
| ENC001951 |  |
0.661 | D0U3YB |  |
0.244 | ||